SAC Capital Advisors’s Cytokinetics CYTK Stock Holding History

SAC Capital Advisors’s Portfolio CYTK Stock Details CYTK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q2	–	Sell	-700,500	Closed	-$6.66M	–	270
2014 Q1	$6.66M	Buy	+700,500	New	+$6.34M	0.03%	505
2013 Q4	–	Sell	-15,403	Closed	-$117K	–	1808
2013 Q3	$117K	Buy	+15,403	New	+$165K	﹤0.01%	1676

Other funds holding CYTK

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

LPU

Lansdowne Partners (UK) London, United Kingdom $1.87B AUM 61.55% 1-Year Est. Return

AWG

Alpha Wave Global New York $791M AUM 113.77% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

IIM

Ironwood Investment Management Boston, Massachusetts $240M AUM 45.82% 1-Year Est. Return

SAC Capital Advisors's CYTK Position: Q2 2014 in Review

SAC Capital Advisors sold out of Cytokinetics (CYTK) in Q2 2014, closing a stake of 700,500 shares — an estimated $6.66M sold.

SAC Capital Advisors first reported a position in CYTK in Q3 2013 and held it in 2 quarters. The position peaked at $6.66M in Q1 2014. 89 funds tracked by Wall St. Rank hold CYTK as of Q2 2014.

SAC Capital Advisors reported no remaining Cytokinetics position as of Q2 2014 after selling out during the quarter.
SAC Capital Advisors sold 700,500 Cytokinetics shares in Q2 2014, an estimated $6.66M.
SAC Capital Advisors first reported a position in Cytokinetics in Q3 2013 and held it in 2 quarters.
SAC Capital Advisors's Cytokinetics position peaked at $6.66M in Q1 2014.
89 funds tracked by Wall St. Rank held Cytokinetics as of Q2 2014.

Based on SAC Capital Advisors's 13F filing for Q2 2014.